..."The company will now pursue merger and acquisition opportunities
to expand its clinical-stage pipeline, given its strong cash position.
Progen said that at June 30 it had $76.7 million cash, excluding
creditors and accruals of $6.2 million"
...That's why I bought in today not quite at 0.58 but a good price never less !!!
..."The company will now pursue merger and acquisition...
-
- There are more pages in this discussion • 146 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
